KR910007883A - 퀴놀린 유도체, 그의 제조방법 및 용도 - Google Patents
퀴놀린 유도체, 그의 제조방법 및 용도 Download PDFInfo
- Publication number
- KR910007883A KR910007883A KR1019900015908A KR900015908A KR910007883A KR 910007883 A KR910007883 A KR 910007883A KR 1019900015908 A KR1019900015908 A KR 1019900015908A KR 900015908 A KR900015908 A KR 900015908A KR 910007883 A KR910007883 A KR 910007883A
- Authority
- KR
- South Korea
- Prior art keywords
- lower alkyl
- formula
- salt
- quinolyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (12)
- 하기식(I)의 퀴놀린 유도체 또는 그의 염.(상기식에서, A, B 및 C의 각각의 페닐고리는 1이상의 치환기를 가질수 있으며 X는(식중에서 R1은 수소원자 또는 저급알킬기임) 또는(식중에서는 R2는 저급알킬기 또는 저급알킬시기임)이고 및 n은 0 또는 1임.)
- 제1항에 있어서, n이 0이고(식중에서, R1은 저급알킬기임)인 화합물.
- 제1항에 있어서, n이 0이고(식중에서, R1은 저급알킬기임)이고, 고리A는 하나 또는 두개의 저급알킬 또는 할로겐 치환기를 가지며, 고리 B는 하나의 할로겐 또는 저급알킬 치환기 또는 두개의 저급알콕시 치환기를 가지며, 고리 C는 두개의 할로겐 치환기 또는 동일 또는 다른 두개의 저급알킬 치환기를 갖는 화합물 .
- 제1항에 있어서, n이 0이고,(식중에서 R1은 메탈임)이고 고리 A는 하나 또는 두개의 메틸 또는 에틸, 이소프로필 또는염소 치환기를 가지며, 고리B는 염소 또는 메틸 치환기 또는 두개의 메톡시 치환기를 가지며, 고리는 두개의 플루오린 치환기 또는 이소프로필 및 메틸 치환기를 갖는 화합물.
- 제1항에 있어서 N-〔4(2-클로로페닐)-1,6,7-트리메틸-1,2-디히드로-2-옥소-3-퀴놀릴〕-N´-(2,4-디플루오로페닐)우레아. N-〔4-(2-클로로페닐)-1-에틸-1,2-디히드로-6,8-디메틸-2-옥소-3-퀴놀릴〕-N´-(2,4-디플루오로페닐)우레아. N-(2,4-디플루오로페닐)-N´-〔1,2-디히드로-1,6,7-트리메틸-4-(2-메틸페닐-2-옥소-3-퀴놀릴〕우레아. N-(2,4-디플루오로페닐)-N´-〔1,2-디히드로-4-(3,4-디메톡시페닐-1,6-디메틸-2-옥소-3-퀴놀릴〕우레아. N-〔4-(2-클로로페닐)-1,2-디히드로-6-에틸-1-메틸-2-옥소-3-퀴놀릴〕-N´-(2,4-디플루오로페닐)우레아. N-〔4-(2-클로로페닐)-1,2-디히드로-6-에틸-1-메틸-2-옥소-3-퀴놀릴〕-N´-(2-이소프로필-6-메틸로페닐)우레아. N-〔6-클로로-1,2-디히드로-1-메틸-4-(2-메틸페닐)-2-옥소-3-퀴놀릴〕-N´-(2-이소프로필-6-메틸페닐)우레아.N-〔7-클로로-1,2-디히드로-4-(2-메틸페닐)-1,6-디메틸-2-옥소-3-퀴놀릴〕-N´-(2,4-디플루오로페닐)우레아. 또는 그의 염인 화합물.
- 제1항에 따른 식(I)의 퀴놀린 유도체 또는 그의 약학적으로 허용 가능한 염의 약학적 유효량 및 약학적 허용가능한 담체,희석제 또는 부형제로 구성된 아실-CoA: 콜레스테롤아실트랜스퍼라제 저해 조성물.
- 제6항에 있어서, 식(I)의 퀴놀린 유도체 또는 그의 염이 제2항에서 정의된 것인 조성물.
- 제6항에 있어서, 식(I)의 퀴놀린 유도체 또는 그의 염이 제3항에서 정의된 것인 조성물.
- 제6항에 있어서, 식(I)의 퀴놀린 유도체 또는 그의 염이 제4항에서 정의된 것인 조성물.
- 제6항에 있어서, 식(I)의 퀴놀린 유도체 또는 그의 염이 제5항에서 정의된 것인 조성물.
- 하기식(Ⅱ)의 화합물 또는 그의 염을 하기식(Ⅲ)의 화합물 또는 그의 염과 반응시킴을 특징으로 하는 하기식(I)의 퀴놀린 유도체 또는 그의 염의 제조방법.[상기식에서 Q´ 및 Q2는 서로 다르며, -NH2또는 -NCO이고 A, B 및 C의 각각 페닐고리는 하나 이상의 치환기를 가질 수 있으며, X는(식중에서 R1은 수소원자 또는 저급알킬기임)또는(식중에서 R2는 저급알킬기 또는 저급알콕시기임)이고 및 n은 0 또는 1임.]
- 제1항에 따른 화합물의 유효량을 그것이 결핍된 환자에게 투여함을 특징으로 하는 아실 -CoA: 콜레스테롤아실트랜스퍼라제의 저해 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP262782/1989 | 1989-10-06 | ||
JP26278289 | 1989-10-06 | ||
JP322290/1989 | 1989-12-11 | ||
JP32229089 | 1989-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR910007883A true KR910007883A (ko) | 1991-05-30 |
Family
ID=26545706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900015908A KR910007883A (ko) | 1989-10-06 | 1990-10-06 | 퀴놀린 유도체, 그의 제조방법 및 용도 |
Country Status (17)
Country | Link |
---|---|
US (1) | US5223513A (ko) |
EP (1) | EP0421456B1 (ko) |
KR (1) | KR910007883A (ko) |
CN (1) | CN1050715A (ko) |
AT (1) | ATE116301T1 (ko) |
AU (1) | AU629048B2 (ko) |
CA (1) | CA2026890C (ko) |
DE (1) | DE69015541T2 (ko) |
FI (1) | FI904915A0 (ko) |
HU (1) | HUT55364A (ko) |
IE (1) | IE903454A1 (ko) |
IL (1) | IL95839A (ko) |
NO (1) | NO904300L (ko) |
NZ (1) | NZ235582A (ko) |
PT (1) | PT95515A (ko) |
RU (1) | RU2001910C1 (ko) |
TW (1) | TW205037B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
JPH0776215B2 (ja) * | 1991-04-26 | 1995-08-16 | フアイザー・インコーポレイテツド | 4−アリール−3−(ヘテロアリールウレイド)キノリン誘導体 |
CA2128093C (en) * | 1992-01-23 | 1998-02-03 | Ernest S. Hamanaka | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
TW241258B (ko) * | 1992-04-15 | 1995-02-21 | Takeda Pharm Industry Co Ltd | |
JPH07503737A (ja) * | 1992-05-28 | 1995-04-20 | フアイザー・インコーポレイテツド | アシル補酵素a:コレステロールアシルトランスフェラーゼ(acat)の阻害剤としての新規なn−アリールおよびn−ヘテロアリール尿素誘導体 |
ATE161530T1 (de) * | 1992-09-04 | 1998-01-15 | Takeda Chemical Industries Ltd | Kondensierte heterozyklische verbindungen, deren herstellung und verwendung |
US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
TW263498B (ko) * | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
US6133326A (en) | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
WO1999009983A1 (en) * | 1997-08-28 | 1999-03-04 | Bristol-Myers Squibb Company | 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators |
US6300500B1 (en) | 1998-02-25 | 2001-10-09 | Sumitomo Pharmaceuticals Company, Limited | Preparation of pyridone derivatives using phthalimido containing starting material |
US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
DZ3288A1 (en) | 2000-02-02 | 2001-08-09 | Warner Lambert Co | Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
CN1234691C (zh) * | 2001-03-02 | 2006-01-04 | 住友化学工业株式会社 | 喹啉-3-羧酸化合物的制备方法 |
AU2004276237B2 (en) | 2003-09-23 | 2008-08-21 | Merck Sharp & Dohme Corp. | Quinoline potassium channel inhibitors |
KR20140088194A (ko) * | 2011-11-04 | 2014-07-09 | 에프. 호프만-라 로슈 아게 | 아릴-퀴놀린 유도체 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1216878B (de) * | 1963-04-02 | 1966-05-18 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins |
NO133758C (ko) * | 1970-04-04 | 1976-06-23 | Takeda Chemical Industries Ltd | |
JPS555502B1 (ko) * | 1971-07-31 | 1980-02-07 | ||
US4530931A (en) * | 1983-01-03 | 1985-07-23 | Usv Pharmaceutical Corp. | 8-Quinoline carbanilates for the inhibition of lipolysis |
DE3586445T2 (de) * | 1984-06-26 | 1993-01-14 | Merck & Co Inc | Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen. |
IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
-
1990
- 1990-09-20 TW TW079107912A patent/TW205037B/zh active
- 1990-09-25 IE IE345490A patent/IE903454A1/en unknown
- 1990-09-25 US US07/587,795 patent/US5223513A/en not_active Expired - Fee Related
- 1990-09-28 AU AU63707/90A patent/AU629048B2/en not_active Ceased
- 1990-09-28 IL IL9583990A patent/IL95839A/en not_active IP Right Cessation
- 1990-10-03 NO NO90904300A patent/NO904300L/no unknown
- 1990-10-04 PT PT95515A patent/PT95515A/pt not_active Application Discontinuation
- 1990-10-04 CA CA002026890A patent/CA2026890C/en not_active Expired - Fee Related
- 1990-10-05 HU HU906360A patent/HUT55364A/hu unknown
- 1990-10-05 AT AT90119128T patent/ATE116301T1/de not_active IP Right Cessation
- 1990-10-05 NZ NZ235582A patent/NZ235582A/en unknown
- 1990-10-05 CN CN90108222A patent/CN1050715A/zh active Pending
- 1990-10-05 DE DE69015541T patent/DE69015541T2/de not_active Expired - Fee Related
- 1990-10-05 RU SU904831426A patent/RU2001910C1/ru active
- 1990-10-05 FI FI904915A patent/FI904915A0/fi not_active Application Discontinuation
- 1990-10-05 EP EP90119128A patent/EP0421456B1/en not_active Expired - Lifetime
- 1990-10-06 KR KR1019900015908A patent/KR910007883A/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0421456A2 (en) | 1991-04-10 |
NO904300D0 (no) | 1990-10-03 |
US5223513A (en) | 1993-06-29 |
IL95839A0 (en) | 1991-06-30 |
DE69015541T2 (de) | 1995-06-01 |
HU906360D0 (en) | 1991-04-29 |
NO904300L (no) | 1991-04-08 |
TW205037B (ko) | 1993-05-01 |
JPH03223254A (ja) | 1991-10-02 |
NZ235582A (en) | 1992-03-26 |
AU6370790A (en) | 1991-04-11 |
ATE116301T1 (de) | 1995-01-15 |
IE903454A1 (en) | 1991-04-10 |
HUT55364A (en) | 1991-05-28 |
EP0421456A3 (en) | 1991-05-29 |
DE69015541D1 (de) | 1995-02-09 |
CA2026890C (en) | 2001-09-18 |
IL95839A (en) | 1995-03-15 |
FI904915A0 (fi) | 1990-10-05 |
PT95515A (pt) | 1991-08-14 |
RU2001910C1 (ru) | 1993-10-30 |
EP0421456B1 (en) | 1994-12-28 |
CA2026890A1 (en) | 1991-04-07 |
CN1050715A (zh) | 1991-04-17 |
AU629048B2 (en) | 1992-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR910007883A (ko) | 퀴놀린 유도체, 그의 제조방법 및 용도 | |
RU92004336A (ru) | Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты | |
HUP0001446A2 (hu) | HIV reverz transzkriptáz inhibitor hatású 4,4-diszubsztituált-3,4-dihidro-2(1H)-kinazolinon-származékok, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
DE68906552T2 (de) | Camptothecin-Derivate und Verfahren zu ihrer Herstellung. | |
NO940737D0 (no) | Antidepressive midler | |
DK0389282T3 (da) | Xanthinderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse | |
CA2011346A1 (en) | 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same | |
ATE152719T1 (de) | Chinolylbenzofuran derivate als leukotrien- antagonisten | |
EP0242789A3 (en) | Novel quinoline derivates and processes for preparation thereof | |
ES481549A1 (es) | Un procedimiento para la producicion de un derivado de feni-letanolamina. | |
GB1495526A (en) | Chroman derivatives | |
ATE139233T1 (de) | Annelierte thiophen-derivate, ihre herstellung und verwendung | |
DE3853577D1 (de) | Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen. | |
CA1272482C (en) | QUINOLINECARBOXYLIC ACID DERIVATIVES | |
SE0101579D0 (sv) | New compounds | |
ATE34976T1 (de) | Arylcyclobutylalkylamine und ihre verwendung als antidepressive arzneimittel. | |
ATE95816T1 (de) | 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung. | |
DE68913365T2 (de) | 4-Amino-3-carboxynaphthyridin-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen. | |
HUP9904594A2 (hu) | Piperazinoszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
KR970703301A (ko) | 신규 디아미노메틸리덴 유도체(novel diamincmethylidene derivative) | |
KR960022476A (ko) | 디페닐 디설파이드 화합물 | |
EA200301171A1 (ru) | Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их | |
KR900011769A (ko) | 신규 벤조[1,8] 나프티리딘 유도체 및 그의 제법 | |
DE69624459T2 (de) | Kondensierte indan-derivate und ihre salze | |
ES2010225A6 (es) | Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SUBM | Surrender of laid-open application requested |